Veterans lobby for MDMA approval for PTSD treatment
Summary: Veterans are lobbying for FDA approval of MDMA-assisted therapy for PTSD, with a decision expected by August 11. In June, an FDA advisory committee overwhelmingly rejected the drug's evidence, citing research flaws. Two phase 3 trials showed over 70% of participants no longer met PTSD criteria after treatment. Controversies surrounding trial conduct and safety concerns complicate the approval process, with public advocacy playing a significant role.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings